Direct-to-patient (DTP) readiness assessment

Direct‑to‑patient (DTP) models are increasingly part of how life sciences organizations think about access, affordability, and patient engagement. As pricing pressures, policy dynamics, and patient expectations evolve, direct models are often explored to simplify pathways and retain greater control over the patient experience.

DTP is not one‑size‑fits‑all. Not every asset, indication, or market is positioned to benefit from a direct approach, and when applied without a clear understanding of fit, DTP models can introduce unintended pricing, access, operational, and long‑term value risk.

Acumetis helps life sciences leaders evaluate DTP not as a shortcut, but as a strategic decision. Our direct‑to‑patient readiness assessment provides a structured way to understand whether, where, and how a DTP approach aligns with an asset’s clinical profile, access environment, commercial strategy, and operational realities, before commitments are made.

In just a few minutes, you’ll receive a data-driven readiness score that highlights opportunity areas, strategic gaps, and where DTP can deliver measurable value.

Start the Assessment →   DTP Readiness Assessment

What is the DTP readiness assessment tool?

Our direct‑to‑patient readiness assessment is a self‑guided, fact‑based framework designed to clarify if, where, and how a product can succeed in a direct‑to‑patient model. It distills complex market, access, and patient dynamics into a single readiness signal, helping teams make more informed strategic decisions with greater confidence.

A strategic tool for smarter DTP decisions

The question is not whether direct‑to‑patient approaches can increase awareness or attract attention. The question is whether they will meaningfully move the needle for a product and the patients it serves.

Our DTP readiness assessment translates complex market, access, and behavioral considerations into a clear readiness signal, helping teams focus effort where DTP can deliver the most impact by:
→ Evaluate your product’s suitability for DTP engagement
→ Assess high-value opportunities and market constraints
→ Focus your launch and access strategy where DTP can deliver the most impact

In some cases, the results indicate a clear opportunity for broader application. In others, they point toward a more targeted, phased, or hybrid approach.
In every case, the goal is the same: to provide clarity and confidence in the path forward.

Why use the direct‑to‑patient readiness assessment?

Developed by Acumetis, the DTP readiness assessment bridges data, strategy, and patient insight to guide commercialization and access decision‑making. It is designed to help teams move from exploration to evidence, replacing assumptions with clarity.

The assessment is:

• Strategic, not speculative, grounded in real‑world access, patient, and market frameworks
• Fast but meaningful, completed in minutes while delivering actionable insight
• Comprehensive in lens, blending access, behavioral, digital, and operational considerations
• Scalable in application, relevant across early planning, launch, and in‑line optimization

How the assessment works

Responses are analyzed across four core DTP readiness pillars, each capturing a critical dimension of potential performance. Each pillar is assessed as low, medium, or high, and together they aggregate into a single DTP readiness score that reflects overall opportunity and risk balance.

This approach allows teams to understand not only where opportunities may exist, but also what trade‑offs and constraints must be addressed for a DTP approach to succeed sustainably.

Assessment inputs

To ensure accuracy, the assessment evaluates multiple parameters that influence DTP success. These inputs allow the algorithm to deliver a readiness profile grounded in real-world access, behavioral, and digital market data.

Your readiness score

Once complete, the tool instantly generates your personalized DTP readiness score. Your score concisely signals where your product stands today and where strategic refinement could unlock greater value.

The result is not an endpoint but a foundation to:

• Test different market scenarios and patient behaviors
• Identify where digital access or behavioral interventions can amplify performance
• Refine launch and commercialization strategy

For tailored interpretation, Acumetis experts can help transform your readiness score into a targeted, actionable roadmap.

From exploration to decision‑ready clarity

Direct‑to‑patient models can create opportunity, but only when applied with a clear understanding of fit, trade‑offs, and long‑term implications. The Acumetis direct‑to‑patient readiness assessment helps teams move from initial interest to informed decision‑making, grounded in connected insight and practical judgment.

Reframe what’s possible through direct model approaches. Take our direct‑to‑patient readiness assessment to understand whether a DTP approach fits your asset and access strategy.

Start the Assessment →   DTP Readiness Assessment